Cubist Systematic Strategies’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,482	Closed	-$234K	–	3316
2021 Q2	$234K	Buy	8,482 +2,878	+51%	+$56.6K	﹤0.01%	2463
2021 Q1	$92K	Sell	5,604 -40,431	-88%	-$921K	﹤0.01%	2659
2020 Q4	$848K	Buy	46,035 +15,106	+49%	+$270K	0.01%	1482
2020 Q3	$421K	Buy	30,929 +18,088	+141%	+$279K	0.01%	1841
2020 Q2	$230K	Buy	+12,841	New	+$194K	﹤0.01%	1973
2020 Q1	–	Sell	-15,889	Closed	-$129K	–	2594
2019 Q4	$129K	Buy	+15,889	New	+$147K	﹤0.01%	2139

Cubist Systematic Strategies's TBIO Position: Q3 2021 in Review

Cubist Systematic Strategies sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 8,482 shares — an estimated $234K sold.

Cubist Systematic Strategies first reported a position in TBIO in Q4 2019 and held it in 6 quarters. The position peaked at $848K in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Cubist Systematic Strategies reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 8,482 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $234K.
Cubist Systematic Strategies first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
Cubist Systematic Strategies's Translate Bio, Inc. Common Stock position peaked at $848K in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Cubist Systematic Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.